J. A. Traver

478 total citations
17 papers, 336 citations indexed

About

J. A. Traver is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, J. A. Traver has authored 17 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Surgery. Recurrent topics in J. A. Traver's work include Hepatitis C virus research (5 papers), Muscle and Compartmental Disorders (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). J. A. Traver is often cited by papers focused on Hepatitis C virus research (5 papers), Muscle and Compartmental Disorders (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). J. A. Traver collaborates with scholars based in Spain, Netherlands and Czechia. J. A. Traver's co-authors include Guillermina Barril, Enrique Gruss, José M. Mato, G.I. de Jong, César García-Cantón, Vicente Paraíso, P.G.M. Luiten, Á Figuera, José Francisco Tomás and Isabel Varela‐Nieto and has published in prestigious journals such as Biochemical Pharmacology, Nephrology Dialysis Transplantation and Journal of Medical Virology.

In The Last Decade

J. A. Traver

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. A. Traver Spain	11	114	100	67	59	42	17	336
Crystal Miller United States	13	54 0.5×	146 1.5×	50 0.7×	204 3.5×	13 0.3×	25	395
Mechthild Beste Germany	11	131 1.1×	144 1.4×	26 0.4×	148 2.5×	10 0.2×	20	470
Hidehiko Kashiwabara Japan	10	22 0.2×	31 0.3×	15 0.2×	72 1.2×	27 0.6×	36	284
E. Pardini Italy	5	56 0.5×	39 0.4×	17 0.3×	59 1.0×	12 0.3×	8	442
P. Gollapudi United States	7	61 0.5×	16 0.2×	20 0.3×	53 0.9×	26 0.6×	9	369
Kyo M Japan	7	37 0.3×	38 0.4×	14 0.2×	110 1.9×	10 0.2×	26	339
Ryoichi Miyazaki Japan	9	30 0.3×	22 0.2×	59 0.9×	67 1.1×	54 1.3×	23	275
Leslie Rees United Kingdom	9	75 0.7×	13 0.1×	10 0.1×	104 1.8×	38 0.9×	12	401
Tsutomu Ishizuka Japan	9	64 0.6×	13 0.1×	28 0.4×	175 3.0×	24 0.6×	15	496
George Drivas Greece	8	35 0.3×	26 0.3×	19 0.3×	103 1.7×	51 1.2×	22	288

Countries citing papers authored by J. A. Traver

Since Specialization

Citations

This map shows the geographic impact of J. A. Traver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Traver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Traver more than expected).

Fields of papers citing papers by J. A. Traver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Traver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Traver. The network helps show where J. A. Traver may publish in the future.

Co-authorship network of co-authors of J. A. Traver

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Traver. A scholar is included among the top collaborators of J. A. Traver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Traver. J. A. Traver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Barril, Guillermina, Javier Bartolomé, Paloma Sanz, et al.. (2010). Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels. Journal of Medical Virology. 82(5). 763–767. 3 indexed citations

Barril, Guillermina & J. A. Traver. (2003). Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Research. 60(2). 129–134. 46 indexed citations

Barril, Guillermina, et al.. (2001). Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. Journal of Medical Virology. 63(2). 103–107. 25 indexed citations

López‐Alcorocho, Juan Manuel, Guillermina Barril, Nuria Ortiz‐Movilla, et al.. (2001). Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. Journal of Medical Virology. 63(2). 103–107. 3 indexed citations

Barril, Guillermina, et al.. (2000). Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially. Journal of Medical Virology. 60(2). 139–143. 8 indexed citations

Sanz, Juan Carlos, et al.. (1998). Eradication and Follow-Up of Helicobacter pylori Infection in Hemodialysis Patients. The Nephron journals/Nephron journals. 79(1). 55–60. 33 indexed citations

Bernis, C., et al.. (1997). Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis. Nephrology Dialysis Transplantation. 12(3). 576–577. 11 indexed citations

Miguel, Eugenio de, et al.. (1996). Outcome of acute renal failure in the elderly: a different approach. Nephrology Dialysis Transplantation. 11(8). 1672–1673. 1 indexed citations

Gruss, Enrique, José Francisco Tomás, César García-Cantón, et al.. (1995). Acute Renal Failure in Patients following Bone Marrow Transplantation: Prevalence, Risk Factors and Outcome. American Journal of Nephrology. 15(6). 473–479. 87 indexed citations

10.

Barril, Guillermina & J. A. Traver. (1995). Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrology Dialysis Transplantation. 10(supp6). 78–80. 19 indexed citations

11.

Bernis, C., et al.. (1995). Role of parathyroid hormone and 1,25 dihydroxycholecalciferol in calcium homeostasis of rhabdomyolysis. Nephrology Dialysis Transplantation. 10(2). 299–300. 5 indexed citations

12.

Bernis, C., et al.. (1995). Renal involvement in the hypereosinophific syndrome. Nephrology Dialysis Transplantation. 10(3). 401–403. 11 indexed citations

13.

Jong, G.I. de, J. A. Traver, & P.G.M. Luiten. (1992). Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application. Mechanisms of Ageing and Development. 64(3). 255–272. 31 indexed citations

14.

Traver, J. A., et al.. (1984). Evidence for generation of leukotriene 84 in human polymorphonuclear leukocytes treated with linoleylanilide. Biochemical Pharmacology. 33(20). 3303–3306. 21 indexed citations

15.

Traver, J. A., Isabel Varela‐Nieto, & José M. Mato. (1984). Effect of exogenous S-adenosyl-l-methionine on phosphatidylcholine synthesis by isolated rat hepatocytes. Biochemical Pharmacology. 33(9). 1562–1564. 19 indexed citations

16.

Traver, J. A., et al.. (1977). Chloramines, an aggravating factor in the anemia of patients on regular dialysis treatment.. PubMed. 14. 192–9. 10 indexed citations

17.

Traver, J. A., et al.. (1970). Topical mafenide in burns.. PubMed. 70(12). 1639–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact